A search for cellular and molecular mechanisms involved in depleted uranium (DU) toxicity
Identifieur interne : 001088 ( Istex/Curation ); précédent : 001087; suivant : 001089A search for cellular and molecular mechanisms involved in depleted uranium (DU) toxicity
Auteurs : Jalal Pourahmad [Iran, Canada] ; Monireh Ghashang [Iran] ; Hossein Ali Ettehadi [Iran] ; Ruhollah Ghalandari [Iran]Source :
- Environmental Toxicology [ 1520-4081 ] ; 2006-08.
English descriptors
- Teeft :
- Acridine, Butylated, Butylated hydroxyanisole, Butylated hydroxytoluene, Control hepatocytes, Cytotoxicity, Dimethyl sulfoxide, Diphenyliodonium chloride, Emission wavelengths, Environmental toxicology, Glutathione, Hepatocyte, Hepatocyte toxicity, Hepatocytes, Inhibitor, Intracellular, Lipid, Lipid peroxidation, Lung cancer, Lysosomal, Membrane, Mitochondrial, Mitochondrial membrane, Molecular mechanisms, Oxygen uptake, Peroxidation, Pourahmad, Reactive, Reduction inhibitor, Reductive, Separate experiments, Tbars, Toxicity, Toxicology, Uorescence, Uorescence spectrophotometer, Uranyl, Uranyl acetate.
Abstract
Addition of U(VI) (uranyl acetate) to isolated rat hepatocytes results in rapid glutathione oxidation, reactive oxygen species (ROS) formation, lipid peroxidation, decreased mitochondrial membrane potential, and lysosomal membrane rupture before hepatocyte lysis occurred. Cytotoxicity was prevented by ROS scavengers, antioxidants, and glutamine (ATP generator). Hepatocyte dichlorofluorescein oxidation was inhibited by mannitol (a hydroxyl radical scavenger) or butylated hydroxyanisole and butylated hydroxytoluene (antioxidants). Glutathione depleted hepatocytes were resistant to U(VI) toxicity and much less dichlorofluorescein oxidation occurred. Reduction of U(VI) by glutathione or cysteine in vitro was also accompanied by oxygen uptake and was inhibited by Ca(II) (a U(IV) or U(VI) reduction inhibitor). U(VI)‐induced cytotoxicity and ROS formation was also inhibited by Ca(II), which suggests that U(IV) and U(IV) GSH mediate ROS formation in isolated hepatocytes. The U(VI) reductive mechanism required for toxicity has not been investigated. Cytotoxicity was also prevented by cytochrome P450 inhibitors, particularly CYP 2E1 inhibitors, but not inhibitors of DT diaphorase or glutathione reductase. This suggests that P450 reductase and reduced cytochrome P450 contributes to U(VI) reduction to U(IV). In conclusion, U(VI) cytotoxicity is associated with mitochondrial/lysosomal toxicity by the reduced biological metabolites and ROS. © 2006 Wiley Periodicals, Inc. Environ Toxicol 21: 349–354, 2006.
Url:
DOI: 10.1002/tox.20196
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001088
Links to Exploration step
ISTEX:6C5107EA0EF5A07DA4B4DCB1987539CAA1011F91Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A search for cellular and molecular mechanisms involved in depleted uranium (DU) toxicity</title>
<author><name sortKey="Pourahmad, Jalal" sort="Pourahmad, Jalal" uniqKey="Pourahmad J" first="Jalal" last="Pourahmad">Jalal Pourahmad</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: j.pourahmadjaktaji@utoronto.ca</mods:affiliation>
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Correspondence address: Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Correspondence address: Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ghashang, Monireh" sort="Ghashang, Monireh" uniqKey="Ghashang M" first="Monireh" last="Ghashang">Monireh Ghashang</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ettehadi, Hossein Ali" sort="Ettehadi, Hossein Ali" uniqKey="Ettehadi H" first="Hossein Ali" last="Ettehadi">Hossein Ali Ettehadi</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ghalandari, Ruhollah" sort="Ghalandari, Ruhollah" uniqKey="Ghalandari R" first="Ruhollah" last="Ghalandari">Ruhollah Ghalandari</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6C5107EA0EF5A07DA4B4DCB1987539CAA1011F91</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/tox.20196</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-RGWMZZQT-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001088</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001088</idno>
<idno type="wicri:Area/Istex/Curation">001088</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">A search for cellular and molecular mechanisms involved in depleted uranium (DU) toxicity</title>
<author><name sortKey="Pourahmad, Jalal" sort="Pourahmad, Jalal" uniqKey="Pourahmad J" first="Jalal" last="Pourahmad">Jalal Pourahmad</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: j.pourahmadjaktaji@utoronto.ca</mods:affiliation>
<country wicri:rule="url">Canada</country>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Correspondence address: Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Correspondence address: Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ghashang, Monireh" sort="Ghashang, Monireh" uniqKey="Ghashang M" first="Monireh" last="Ghashang">Monireh Ghashang</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ettehadi, Hossein Ali" sort="Ettehadi, Hossein Ali" uniqKey="Ettehadi H" first="Hossein Ali" last="Ettehadi">Hossein Ali Ettehadi</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ghalandari, Ruhollah" sort="Ghalandari, Ruhollah" uniqKey="Ghalandari R" first="Ruhollah" last="Ghalandari">Ruhollah Ghalandari</name>
<affiliation wicri:level="1"><mods:affiliation>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153, Iran</mods:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, P.O.Box 14155‐6153</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Environmental Toxicology</title>
<title level="j" type="sub">12th International Symposium on Toxicity Assessment</title>
<title level="j" type="alt">ENVIRONMENTAL TOXICOLOGY</title>
<idno type="ISSN">1520-4081</idno>
<idno type="eISSN">1522-7278</idno>
<imprint><biblScope unit="vol">21</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="349">349</biblScope>
<biblScope unit="page" to="354">354</biblScope>
<biblScope unit="page-count">6</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-08">2006-08</date>
</imprint>
<idno type="ISSN">1520-4081</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1520-4081</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acridine</term>
<term>Butylated</term>
<term>Butylated hydroxyanisole</term>
<term>Butylated hydroxytoluene</term>
<term>Control hepatocytes</term>
<term>Cytotoxicity</term>
<term>Dimethyl sulfoxide</term>
<term>Diphenyliodonium chloride</term>
<term>Emission wavelengths</term>
<term>Environmental toxicology</term>
<term>Glutathione</term>
<term>Hepatocyte</term>
<term>Hepatocyte toxicity</term>
<term>Hepatocytes</term>
<term>Inhibitor</term>
<term>Intracellular</term>
<term>Lipid</term>
<term>Lipid peroxidation</term>
<term>Lung cancer</term>
<term>Lysosomal</term>
<term>Membrane</term>
<term>Mitochondrial</term>
<term>Mitochondrial membrane</term>
<term>Molecular mechanisms</term>
<term>Oxygen uptake</term>
<term>Peroxidation</term>
<term>Pourahmad</term>
<term>Reactive</term>
<term>Reduction inhibitor</term>
<term>Reductive</term>
<term>Separate experiments</term>
<term>Tbars</term>
<term>Toxicity</term>
<term>Toxicology</term>
<term>Uorescence</term>
<term>Uorescence spectrophotometer</term>
<term>Uranyl</term>
<term>Uranyl acetate</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Addition of U(VI) (uranyl acetate) to isolated rat hepatocytes results in rapid glutathione oxidation, reactive oxygen species (ROS) formation, lipid peroxidation, decreased mitochondrial membrane potential, and lysosomal membrane rupture before hepatocyte lysis occurred. Cytotoxicity was prevented by ROS scavengers, antioxidants, and glutamine (ATP generator). Hepatocyte dichlorofluorescein oxidation was inhibited by mannitol (a hydroxyl radical scavenger) or butylated hydroxyanisole and butylated hydroxytoluene (antioxidants). Glutathione depleted hepatocytes were resistant to U(VI) toxicity and much less dichlorofluorescein oxidation occurred. Reduction of U(VI) by glutathione or cysteine in vitro was also accompanied by oxygen uptake and was inhibited by Ca(II) (a U(IV) or U(VI) reduction inhibitor). U(VI)‐induced cytotoxicity and ROS formation was also inhibited by Ca(II), which suggests that U(IV) and U(IV) GSH mediate ROS formation in isolated hepatocytes. The U(VI) reductive mechanism required for toxicity has not been investigated. Cytotoxicity was also prevented by cytochrome P450 inhibitors, particularly CYP 2E1 inhibitors, but not inhibitors of DT diaphorase or glutathione reductase. This suggests that P450 reductase and reduced cytochrome P450 contributes to U(VI) reduction to U(IV). In conclusion, U(VI) cytotoxicity is associated with mitochondrial/lysosomal toxicity by the reduced biological metabolites and ROS. © 2006 Wiley Periodicals, Inc. Environ Toxicol 21: 349–354, 2006.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001088 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001088 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:6C5107EA0EF5A07DA4B4DCB1987539CAA1011F91 |texte= A search for cellular and molecular mechanisms involved in depleted uranium (DU) toxicity }}
This area was generated with Dilib version V0.6.33. |